Possible role of microglial prostanoids and free radicals in neuroprotection and neurodegeneration

Advances in Experimental Medicine and Biology

Volumn 468, Issue , 2000, Pages 109-119

  Minghetti L ^a   Polazzi, E ^a   Nicolini A ^a   Greco, A ^a   Levi, G ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; PROSTANOID;

ANIMAL CELL; CELL DEATH; CELL PROTECTION; CONFERENCE PAPER; CYTOTOXICITY; EFFECTOR CELL; IMMUNE RESPONSE; MICROGLIA; MOLECULAR INTERACTION; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SPREADING CORTICAL DEPRESSION;

ANIMALS; CENTRAL NERVOUS SYSTEM; FREE RADICALS; HUMANS; MICROGLIA; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; PROSTAGLANDINS;

ANIMALIA;

EID: 0034463502     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (76)

1. Reversible inhibitory effects of interferon-γ and tumor necrosis factor-α on oligodendroglial lineage cell proliferation and differentiation in vitro
2. 2 protects cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity
3. IL-12 production by central nervous system microglia is inhibited by astrocytes
4. Induction of cyclo-oxygenase and nitric oxide synthase in inflammation
5. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis
6. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia
7. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains
8. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death
9. Long term elevation of cyclooxygemase-2, but not lipoxygenase, in regions synaptically distant fron spreading depression
10. The adhesion molecule and cytokine profile of multiple sclerosis lesions
11. 2) protects rat cortical neurons in culture against hypoxia/reoxygenation and glutamate-induced injury
12. Protection by prostaglandins from glutamate toxicity in cortical neurons
13. Activated microglia mediate neuronal cell death injury via a nitric oxide mechanism
14. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism
15. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene
16. Expression of cyclo-oxygenase 2 in rat brain following kainate treatment
17. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice
18. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures
19. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions
20. Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyielitis in SJL/J mice
21. Excitatory amino acid receptors, neural membrane phospholipid metabolism, and neurological disorders
22. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene
23. Lipocortin-1: Cellular mechanisms and clinical relevance
24. Potential role of prostaglandins and leukotrienes in multiple sclerosis and experimental allergic encephalomyelitis
25. Mediator release in cerebrospinal fluid of human immunodeficiency virus-positive patients with central nervous system involvement
26. Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system
27. Growth control of cultured microglia
28. The effect of steroid treatment on lipocortin immunoreactivity of rat brain
29. Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia
30. Neuroprotection by aspirin and sodium salicylate through blokade of NF-kB activation
31. Nitric oxide: Pathophysiological mechanisms
32. Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages
33. Prostaglandin D synthase is the key enzyme in the promotion of physiological sleep
34. The oxidation of α-tocopherol in human low-density lipoprotein by the simultaneous generation of superoxide and nitric oxide
35. Inhibition of low-density lipoprotein oxidation by nitric oxide
36. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex
37. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery
38. Expression pattern of messenger RNAs for prostanoid receptors in glial cell cultures
39. Inhibition of NF-kB by sodium salicylate and aspirin
40. Microglia: A sensor for pathological events in the CNS
41. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases
42. Lipocortin 1 immunoreactivity identifies microglia in adult rat brain
43. Activation of microglial cells by β-amyloid protein and interferon-γ
44. 2, and cyclic AMP-elevating agents
45. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide
46. Induction of prostanoid biosynthesis by bacterial lipopolysaccharide and isoproterenol in rat microglial cultures
47. Interferon-γ and nitric oxide down-regulate lipopolysaccharide-induced prostanoid production in cultured rat microglial cells by inhibiting cyclooxygenase-2 expression
48. 2 and by cyclooxygenase inhibitors
49. 2, cyclic AMP and non steroidal anti-inflammatory drugs
50. Opposite regulation of prostaglandin E2 synthsis by transformung growth factor-β1 and interleukin 10 in activated microglial cultures
51. Microglia as effector cells in brain damage and repair: Focus on prostanoids and nitric oxide
52. Interleukin-10
53. Cytokines and pathogenesis of multiple sclerosis
54. Interferon-γ and lipopolysaccharide reduce cAMP responses in cultured glial cells: Reversal by a type IV phosphodiesterase inhibitor
55. Selective enhancement by serum factors of cyclic AMP accumulation in microglia cultures
56. Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse. A qualitative comparison with an anti-CD11b monoclonal antibody
57. A new view of prostaglandin E regulation of the immune response
58. Prostaglandins sensitize nociceptors in cell culture
59. Prostaglandins and inhibitors of arachidonate metabolism suppress experimental allergic encephalomyelitis
60. Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain
61. Eicosanoids, thermogenesis, and thermoregulation
62. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation
63. Mice with an inactivation of the inducble nitric oxide synthase gene are scusceptible to experimental autoimmune encephalomyelitis
64. Production of interleukin-5 by mouse astrocytes and microglia in culture
65. 2 and the a subtype of protein kinase C
66. A pharmacological study on the role of nitric oxide in the pathogenesis of experimental allergic encephalomyelitis
67. Arachidonic acid cascade and signal transduction
68. Progressive activation of adult microglial cells in vitro
69. Re-orientation of prostanoid production accompanies "activation" of adult microglial cells in culture
70. 2 and a β-adrenergic agonist
71. Appearance of inducible nitric oxide synthase in the rat central nervous system after rabies virus infection and during experimental allergic encephalomyelitis but not after peripheral administration of endotoxin
72. Prostaglandins as modulators rather than mediators of inflammation
73. Nitric oxide protects against cellular damage and cytotoxycity from reactive oxygen species
74. Chemical biology of nitric oxide: Regulation and protective and toxic mechanisms
75. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids
76. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis